Measure Type: High Priority
CAHPS for MIPS SSM: Health Promotion and Education
CAHPS for MIPS SSM: Shared Decision Making
CAHPS for MIPS SSM: Health Status and Functional Status
CAHPS for MIPS SSM: Care Coordination
CAHPS for MIPS SSM: Courteous and Helpful Office Staff
CAHPS for MIPS SSM: Stewardship of Patient Resources
Urinary Bladder Cancer: Complete Analysis and Timely Reporting
Percentage of urinary bladder carcinoma pathology reports that include the procedure, histologic tumor grade, histologic type, presence/absence of muscularis propria, presence/absence of lymphovascular invasion, and tumor extent.
AND
meet the maximum 2 business day turnaround time (TAT) requirement (Report Date – Accession Date is less than or equal to 2 business days).
INSTRUCTIONS: This measure has two performance rates that contribute to the overall performance score:
Stratum 1. Percent of cases for which all required data elements of the urinary bladder carcinoma pathology report are included.
Stratum 2. Percent of cases that meet the maximum 2 business day turnaround time.
The overall performance score submitted is a weighted average of:
(Performance rate 1 x 70%)+(Performance rate 2 x 30%)
Molecular Assessment: Biomarkers in Non-Small Cell Lung Cancer
Percentage of non-small cell lung cancer (NSCLC) pathology reports that include anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR), AND tyrosine protein kinase ROS1 mutation status.
Stones: Repeat Shock Wave Lithotripsy (SWL) Within 6 Months of Initial Treatment
Percentage of patients who underwent repeat Shock Wave Lithotripsy within 6 months of initial procedure